We screened a panel of monoclonal antibodies against selected macrophage cell surface molecules for their ability to inhibit enterotoxin binding to major histocompatibility complex class II-negative C2D (H-2b) macrophages. Two monoclonal antibodies, HB36 and TIB126, that are specific for the a2 domain of major histocompatibility complex class I, blocked staphylococcal enterotoxins A and B (SEA and SEB, respectively) binding to C2D macrophages in a specific and concentration-dependent manner. Inhibitory activities were haplotype-specific in that SEA and SEB binding to H-2k or H-2d macrophages was not inhibited by either monoclonal antibody. HB36, but not TIB126, inhibited enterotoxin-induced secretion of cytokines by H-2b macrophages. Lastly, passive protection of D-galactosamine-sensitized C2D mice by injection with HB36 antibody prevented SEB-induced death. Therefore, SEA and SEB binding to the a2 domain of the H-2Db molecule induces biological activity and has physiological consequences.
There is extensive data demonstrating that major histocompatibility complex class II (MHC II) molecules are receptors for superantigens (1) (2) (3) . At least two binding sites have been described on MHC II molecules outside of the peptide binding site (4) (5) (6) . Recent evidence published by our group indicates that an additional murine macrophage receptor exists that is distinct from the MHC 11 molecules (7) and interacts specifically with staphylococcal exotoxins. Binding causes macrophage activation, but the nature of the alternative binding receptor is unclear. We identified a heterogeneous array of molecules present on peritoneal macrophages from MHC II-negative mice (C2D) that were capable of binding exotoxin (7) . To decipher the nature of the alternative binding site, we screened a panel of monoclonal antibodies specific for MHC class I and other candidate cell surface molecules.
MATERIALS AND METHODS
Mice. Transgenic mice, negative for MHC class II (C2D, H-2b mice) were bred in the rodent facility of the Division of Biology at Kansas State University. We confirmed the absence of MHC II molecules as described (8) . Age-matched C57BL/6 (B6, H-2b) mice, also bred in the rodent facility, served as syngeneic MHC II-positive controls. Age-matched C3H/HeJ (H-2k), BALB/c (H-2d), or C3H.OL (H-2KdDk) mice, bred in our colony, were used in some experiments.
Toxin. Staphylococcal enterotoxins A and B (SEA and SEB, respectively) were obtained from Toxin Technology (Madison, WI) or from the U.S. Army Medical Research and Development command (Ft. Detrick, MD). The exotoxins were free of endotoxin (at <0.001 ng of endotoxin per jug of exotoxin) as determined by the manufacturer or our own analysis (7, 9) .
Cells. Peritoneal macrophages were obtained as described (10) . The tumor necrosis factor a (TNF)-sensitive cell line
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (9) . Positive expression was measured as an increase in mean channel fluorescence when compared to the controls. Binding Assays. SEA and SEB were iodinated as described (7) with a minimum specific activity of 10 ,uCi/,tg (1 Ci = GBq). Specific binding was determined by subtracting the signal obtained from 125I-labeled toxin in the presence of 100-fold excess of unlabeled toxin from the signal obtained with labeled toxin alone. All treatments were done in triplicate and the experiment was repeated a minimum of three times. Cytokine Secretion and Quantitation. Cytokine induction was measured as described (7, 10) . Briefly, macrophages were activated with 0-10 ,ug of toxin per ml and 0-500 ,ug of monoclonal antibody containing polymyxin B (10 ,gg/ml) to inhibit lipopolysaccharide (LPS) macrophage activation (7, 10) . After 18 hr, the supernatants were collected as described (7, 10) . The macrophage supernatants were assayed for and TNF by using the B9 and LM929 bioassays, respectively (7, 10) .
In Vivo Treatment with Toxin. We modified the pathogenicity model of Miethke et al. (11) to induce exotoxin shock in mice (33) . Briefly, mice were sensitized with D-galactosamine (20 concentration-dependent manner by both TIB126 and HB36 (Table 1) . However, even with the addition of 500 ,ug of HB36 and/or TIB126, 125I-labeled toxin binding was never completely inhibited.
These data indicate that SEA and SEB probably also bind to non-MHC II receptors on wild-type macrophages (7, 9 Table 2) .
Effects of Monoclonal Antibodies on Cytokine Secretion. To determine whether the epitope blocked by HB36 or TIB126 was biologically active, we investigated whether addition of either antibody would interfere with toxin-induced macrophage activation. TNF and IL-6 secretion by toxin-or LPSinduced C2D macrophages was similar to previous experiments (7, 10) . HB36 decreased C2D macrophage secretion of TNF and IL-6 by 55 and 50%, respectively, after stimulation with SEA (Table 3 ). HB36 reduced SEB-induced IL-6 secretion by 42%. Since SEB does not induce TNF secretion by murine macrophages (9), the lack of an effect of HB36 on SEB-induced TNF secretion was not meaningful. HB36 alone did not stimulate macrophage production of TNF or IL-6 (Table 3) . In contrast to HB36, TIB126 did not decrease TNF or IL-6 secretion by SEA-or SEB-stimulated C2D macrophages (Table 3 ). In fact, in the absence of other agonists, TIB126 stimulated C2D macrophages to secrete IL-6 (P < 0.05) and TNF (P < 0.1). Neither HB36 nor TIB126 inhibited cytokine secretion by wild-type B6 macrophages (data not shown).
Involvement of MHC I Molecules in Pathogenesis. We investigated the ability of HB36 to prevent SEB-induced pathogenesis in C2D mice. When HB36 was injected with D-galactosamine, Table 5 ). In addition, the tertiary structure of the MHC molecule also influences toxin binding and may not allow for simple linear amino acid comparisons (21, 22 (27) while MHC I-expressing cells regulate CD8+ T cells (28) . Therefore, if MHC I can also bind superantigen, it could explain how they regulate CD8+ T cells. Recent work has implicated superantigens in the etiology of autoimmune diseases such as diabetes (29) . It is difficult to understand how a ligand that binds products of the MHC II genes might be influenced by MHC I gene products since the disease has been linked to MHC I (30) . The specific allelic and gene product binding of enterotoxin would explain the discrepancy. Binding of staphylococcal exotoxins to H-2Db on C2D macrophages also induced cellular activation similar to normal macrophages (7, 10) , indicating that H-2Db serves as a func- 
